Journal of the Neurological Sciences
Volume 229 , Pages 57-63 , 15 March 2005

Understanding the pathology of vascular cognitive impairment

References 

  1. McMenemey WH. The dementias and progressive diseases of the basal ganglia. In:  Greenfield JG editors. Neuropathology. 3rd ed.. London: E. Arnold; 1961;p. 475–521
  2. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974;2:207–210
  3. Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, et al. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 2001;57:714–716
  4. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J. Neurol. Neurosurg. Psychiatry. 1997;63:749–753
  5. Markesbery WR. Vascular dementia. In:  Markesbery W editors. Neuropathology of dementing disorders. London: Arnold Publishers; 1998;p. 293–311
  6. Erkinjuntti T. Cerebrovascular dementia: pathophysiology, diagnosis and treatment. CNS Drugs. 1999;12:35–48
  7. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, et al. Neuropathologic substrates of ischemic vascular dementia. J. Neuropathol. Exp. Neurol. 2000;59:931–945
  8. Jellinger KA. The pathology of ischemic-vascular dementia: an update. J. Neurol. Sci. 2002;203–204:153–157
  9. Jellinger KA. The neuropathological substrate of vascular-ischemic dementia. In:  Paul RH,  Cohen R,  Ott BR,  Salloway S editor. Vascular dementia- cerebrovascular mechanisms and clinical management. Totowa, NJ: Humana Press; 2005;p. 23–56
  10. Bowler JV, Hachinski V. Vascular cognitive impairment. Preventable dementia. Oxford: Oxford Univ. Press; 2003;
  11. Hyman BT. New neuropathological criteria for Alzheimer disease. Arch. Neurol. 1998;55:1174–1176
  12. Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J. Neural Transm. 2002;109:813–836
  13. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473–480
  14. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250–260
  15. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology. 2000;54:S4–S9
  16. Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke. 2000;31:1487–1493
  17. Rahkonen T, Eloniemi-Sulkava U, Rissanen S, Vatanen A, Viramo P, Sulkava R. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J. Neurol. Neurosurg. Psychiatry. 2003;74:720–724
  18. Gorelick PB. Prevention. In:  Bowler JV,  Hachinski V editor. Vascular cognitive impairment. Preventable dementia. Oxford: Oxford Univ. Press; 2003;p. 308–320
  19. Schneider JA, Wilson RS, Cochran EJ, Bienias JL, Arnold SE, Evans DA, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 2003;60:1082–1088
  20. Hulette C, Nochlin D, McKeel D, Morris JC, Mirra SS, Sumi SM, et al. Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology. 1997;48:668–672
  21. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277:813–817
  22. Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, Kondo N, Sato T, et al. Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J. Neurol. Sci. 2002;196:63–69
  23. Seno H, Ishino H, Inagaki T, Iijima M, Kaku K, Inata T. A neuropathological study of dementia in nursing homes over a 17-year period, in Shimane Prefecture, Japan. Gerontology. 1999;45:44–48
  24. Dickson DW, Davies P, Bevona C, Van Hoeven KH, Factor SM, Grober E, et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or =80 years of age) humans. Acta Neuropathol. (Berl.). 1994;88:212–221
  25. Fazekas F, Schmidt R, Kleinert R, Kapeller P, Roob G, Flooh E. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates. J. Neural Transm., Suppl. 1998;53:31–39
  26. Block F. Global ischemia and behavioural deficits. Prog. Neurobiol. 1999;58:279–295
  27. Pantoni L. Subtypes of vascular dementia and their pathogenesis: a critical overview. In:  Bowler JV,  Hachinski V editor. Vascular cognitive impairment-preventable dementia. New York: Oxford University Press; 2003;p. 217–229
  28. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J. Neurol. Sci. 1970;11:205–242
  29. Erkinjuntti T, Benavente O, Eliasziw M, Munoz DG, Sulkava R, Haltia M, et al. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch. Neurol. 1996;53:325–332
  30. Markesbery WR. Overview of vascular dementia. In:  Iqbal K,  Sisodia S,  Winblad B editor. Alzheimer disease: advances in etiology, pathogenetics and therapy. Paris: John Wiley and Sons; 2001;p. 205–220
  31. Mikol J. Vascular dementia. In:  Duckett S,  De La Torre JC editor. Pathology of the aging human nervous system. Oxford: Oxford University Press; 2001;p. 101–122
  32. Fein G, Di Sclafani V, Tanabe J, Cardenas V, Weiner MW, Jagust WJ, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 2000;55:1626–1635
  33. Kril JJ, Patel S, Harding AJ, Halliday GM. Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J. Neurol. Neurosurg. Psychiatry. 2002;72:747–751
  34. del Ser T, Bermejo F, Portera A, Arredondo JM, Bouras C, Constantinidis J. Vascular dementia. A clinicopathological study. J. Neurol. Sci. 1990;96:1–17
  35. Thal DR, Dhebremedhin E, Orantes M, Wiestler OD. Small vessel lesions related to Cerebral Amyloid Angiopathy (CAA) and arteriosclerosis/lipohyalinosis (AS/LH) are associated with Alzheimer disease (abstr.). Brain Pathol. 2003;13(Suppl. 1):S7–S8
  36. Kramer JH, Reed BR, Mungas D, Weiner MW, Chui HC. Executive dysfunction in subcortical ischaemic vascular disease. J. Neurol. Neurosurg. Psychiatry. 2002;72:217–220
  37. Burton E, Ballard C, Stephens S, Kenny RA, Kalaria R, Barber R, et al. Hyperintensities and fronto-subcortical atrophy on MRI are substrates of mild cognitive deficits after stroke. Dement. Geriatr. Cogn. Disord. 2003;16:113–118
  38. Hentschel F, Kreis M, Damian M, Krumm B. Microangiopathic lesions of white matter. Quantitation of cerebral MRI findings and correlation with psychological tests. Nervenarzt. 2003;74:355–361
  39. Cannata AP, Alberoni M, Franceschi M, Mariani C. Frontal impairment in subcortical ischemic vascular dementia in comparison to Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2002;13:101–111
  40. Zhan SS, Beyreuther K, Schmitt HP. Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls. Dementia. 1994;5:79–87
  41. Kimura S, Saito H, Minami M, Togashi H, Nakamura N, Nemoto M, et al. Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats. Toxicology. 2000;153:167–178
  42. Swartz RH, Black SE. How common is vascular compromise of cholinergic white matter pathways in a memory clinic sample?. J. Neurol. Sci. 2002;203–204:281
  43. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 202; 359:1283–90.
  44. Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003;61:479–486
  45. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The consortium to establish a registry for Alzheimer's disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479–486
  46. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143–1153
  47. Lee JH, Olichney JM, Hansen LA, Hofstetter CR, Thal LJ. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch. Neurol. 2000;57:1474–1479
  48. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) . Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet. 2001;357:169–175
  49. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch. Neurol. 1995;52:702–708
  50. Iadecola C. Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia. Cell. Mol. Neurobiol. 2003;23:681–689
  51. Zekry D, Duyckaerts C, Moulias R, Belmin J, Geoffre C, Herrmann F, et al. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol. (Berl.). 2002;103:481–487
  52. Nagy Z, Esiri MM, Jobst KA, Morris JH, King E-F, McDonald B, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J. Neuropathol. Exp. Neurol. 1997;56:165–170
  53. Zekry D, Duyckaerts C, Belmin J, Geoffre C, Herrmann F, Moulias R, et al. The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol. Aging. 2003;24:213–219
  54. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease, CERAD, Part XVIII (abstr.). Neurology. 1998;51:159–162
  55. Crystal H, Dickson D. Cerebral infarcts in patients with autopsy proven Alzheimer's disease (abstr.). Neurobiol. Aging. 2002;23:207
  56. Corbett A, Bennett H, Kos S. Cognitive dysfunction following subcortical infarction. Arch. Neurol. 1994;51:999–1007
  57. Frisoni GB, Geroldi C. Cerebrovascular disease affects noncognitive symptoms in Alzheimer disease. Arch. Neurol. 2001;58:1939–1940

PII: S0022-510X(04)00449-6

doi: 10.1016/j.jns.2004.11.029

Journal of the Neurological Sciences
Volume 229 , Pages 57-63 , 15 March 2005

Article Tools